OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
53
Results
Show all
Save search
Copy query
Show results for
Unknown
(53)
Publication Date
Release Date
2022
(8)
2021
(7)
2016
(6)
2014
(6)
2023
(5)
2015
(5)
2019
(4)
2008
(3)
2025
(2)
2024
(2)
2018
(1)
2017
(1)
2013
(1)
2012
(1)
2011
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.
Not available
S-EPMC4162493
|
biostudies-literature
Cite
Translating evidence in a priority setting partnership: knowledge gaps between healthcare providers and oesophageal cancer patients.
Not available
S-EPMC9860237
|
biostudies-literature
Cite
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Not available
S-EPMC6541928
|
biostudies-literature
Cite
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.
Not available
S-EPMC5303682
|
biostudies-literature
Cite
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.
Not available
S-EPMC10247515
|
biostudies-literature
Cite
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.
Not available
S-EPMC4731690
|
biostudies-literature
Cite
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial.
Not available
S-EPMC8906485
|
biostudies-literature
Cite
Mosquito genomics. Highly evolvable malaria vectors: the genomes of 16 Anopheles mosquitoes.
Not available
S-EPMC4380271
|
biostudies-literature
Cite
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Not available
S-EPMC8639161
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets